NASDAQ OMX Nordic: Derivatives: Adjustment in Karo Pharma due to rights issue (13/19)

Following an authorization from the Extraordinary General Meeting (EGM), held
on September 20, 2019, the board of Karo Pharma has resolved on a rights issue
whereby shareholders are entitled to three (3) new shares for every eight (8)
shares held. The subscription price is SEK 33.00 per share. The Ex-date is
September 30, 2019. NASDAQ Derivatives Markets has carried out a re-calculation
of forwards in Karo Pharma (KAROB). 

For further information, please see the attached file.

Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=739985